Harald Schmidt
Professor & Head of Department of Pharmacology & Personalised Medicine
MeHNS, Faculty of Health, Medicine & Life Science, Maastricht University
Maastricht, Netherlands
My organisation
About me
With a double degree in both Medicine and Pharmacy, Harald Schmidt works in network and systems medicine to re-define what we call "disease" from a descriptive symptom- and organ-based to a mechanism-based approach by using big data, multi-target validation, new mechanism-based diagnostics, and rapid repurposing of registered drugs for new clinical applications by network pharmacology.
He applies this to areas of unmet medical need up to clinical validation. He coordinated the H2020 project REPO-TRIAL on in-silico network pharmacology and is now leading the €25M European drug repurposing platform project REPO4EU, which is planned to become a Permanent European Research Infrastructure.
His multi-national career in Academia (Germany, USA, Australia, Netherlands), Industry (Abbott Labs, Chicago), and Biotech (Vasopharm) have led to drug and diagnostics patents, spin-off companies and several licenses.
Speaker sessions (1)
Monday, 20 October 2025
16:00 - 17:30